Gentiolic acid (2,5-dihydroxybenzoic acid, GA) is the active ingredient of TGX, which can attenuate pressure overload‐induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway [14, 15]. Here, MAPK3 is linked to cardiac hypertrophy.